Loading...

Haw Par Corporation Limited

HAWPYPNK
Healthcare
Drug Manufacturers - General
$28.64
$0.00(0.00%)

Haw Par Corporation Limited (HAWPY) Stock Overview

Explore Haw Par Corporation Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.1/100

Key Financials

Market Cap1.6B
P/E Ratio8.73
EPS (TTM)$2.01
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$26.70

HAWPY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haw Par Corporation Limited (HAWPY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.73 and a market capitalization of 1.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;